1. Home
  2. CTXR vs LRE Comparison

CTXR vs LRE Comparison

Compare CTXR & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • LRE
  • Stock Information
  • Founded
  • CTXR 2007
  • LRE 2001
  • Country
  • CTXR United States
  • LRE Japan
  • Employees
  • CTXR N/A
  • LRE N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • LRE
  • Sector
  • CTXR Health Care
  • LRE
  • Exchange
  • CTXR Nasdaq
  • LRE Nasdaq
  • Market Cap
  • CTXR 22.1M
  • LRE 20.5M
  • IPO Year
  • CTXR N/A
  • LRE 2023
  • Fundamental
  • Price
  • CTXR $1.57
  • LRE $1.62
  • Analyst Decision
  • CTXR Strong Buy
  • LRE
  • Analyst Count
  • CTXR 3
  • LRE 0
  • Target Price
  • CTXR $53.00
  • LRE N/A
  • AVG Volume (30 Days)
  • CTXR 1.6M
  • LRE 134.6K
  • Earning Date
  • CTXR 08-12-2025
  • LRE 01-01-0001
  • Dividend Yield
  • CTXR N/A
  • LRE N/A
  • EPS Growth
  • CTXR N/A
  • LRE N/A
  • EPS
  • CTXR N/A
  • LRE N/A
  • Revenue
  • CTXR N/A
  • LRE $110,330,328.00
  • Revenue This Year
  • CTXR N/A
  • LRE N/A
  • Revenue Next Year
  • CTXR $731.60
  • LRE N/A
  • P/E Ratio
  • CTXR N/A
  • LRE N/A
  • Revenue Growth
  • CTXR N/A
  • LRE 3.92
  • 52 Week Low
  • CTXR $0.65
  • LRE $1.00
  • 52 Week High
  • CTXR $12.84
  • LRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 54.81
  • LRE 51.46
  • Support Level
  • CTXR $1.50
  • LRE $1.32
  • Resistance Level
  • CTXR $1.98
  • LRE $1.74
  • Average True Range (ATR)
  • CTXR 0.22
  • LRE 0.15
  • MACD
  • CTXR -0.00
  • LRE 0.02
  • Stochastic Oscillator
  • CTXR 35.75
  • LRE 55.55

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: